NCT02264080View on ClinicalTrials.gov

Pharmacokinetics and Safety of WAL2014 (Talsaclidine) Administered Orally to Healthy Adult Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 1999

Primary Completion Date

March 31, 1999

Conditions
Healthy
Interventions
DRUG

WAL2014

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY